Deferoxamine for advanced hepatocellular carcinoma

N Engl J Med. 2011 Aug 11;365(6):576-8. doi: 10.1056/NEJMc1105726.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / blood
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / mortality
  • Deferoxamine / adverse effects
  • Deferoxamine / therapeutic use*
  • Female
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / mortality
  • Male
  • Middle Aged
  • Siderophores / adverse effects
  • Siderophores / therapeutic use*
  • Survival Rate

Substances

  • Biomarkers, Tumor
  • Siderophores
  • Deferoxamine